Literature DB >> 11944084

Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines.

P Gomes1, P Soares-da-Silva.   

Abstract

The present study examined the functional characteristics of L-DOPA transporters in two functionally different clonal subpopulations of opossum kidney (OKLC and OKHC) cells. The uptake of L-DOPA was largely Na+-independent, though in OKHC cells a minor component (approximately 15%) required extracellular Na+. At least two Na+-independent transporters appear to be involved in L-DOPA uptake. One of these transporters has a broad specificity for small and large neutral amino acids, is stimulated by acid pH and inhibited by 2-aminobicyclo(2,2,l)-heptane-2-carboxylic acid (BCH; OKLC, Ki = 291 mM; OKHC, Ki = 380 mM). The other Na+-independent transporter binds neutral and basic amino acids and also recognizes the di-amino acid cystine. [14C]-L-DOPA efflux from OKLC and OKHC cells over 12 min corresponded to a small amount of intracellular [14C]-L-DOPA. L-Leucine, nonlabelled L-DOPA, BCH and L-arginine, stimulated the efflux of [14C]-L-DOPA in a Na+-independent manner. It is suggested that L-DOPA uses at least two major transporters, systems LAT-2 and b0,+. The transport of L-DOPA by LAT-2 corresponds to a Na+-independent transporter with a broad specificity for small and large neutral amino acids, stimulated by acid pH and inhibited by BCH. The transport of L-DOPA by system b0,+ is a Na+-independent transporter for neutral and basic amino acids that also recognizes cystine. LAT-2 was found equally important at the apical and basolateral membranes, whereas system b0,+ had a predominant distribution in apical membranes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944084     DOI: 10.1007/s00232-001-0136-8

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  7 in total

1.  Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters.

Authors:  Anees A Banday; Andrea Diaz Diaz; Mustafa Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-14

2.  Gastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.

Authors:  Xiaoliang Jiang; Yanrong Zhang; Yu Yang; Jian Yang; Laureano D Asico; Wei Chen; Robin A Felder; Ines Armando; Pedro A Jose; Zhiwei Yang
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-10-25       Impact factor: 4.310

3.  Genomic regulation of intestinal amino acid transporters by aldosterone.

Authors:  João S Amaral; Maria João Pinho; Patrício Soares-da-Silva
Journal:  Mol Cell Biochem       Date:  2008-03-18       Impact factor: 3.396

Review 4.  Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.

Authors:  Aravind Mittur; Suneel Gupta; Nishit B Modi
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

5.  Mutations in L-type amino acid transporter-2 support SLC7A8 as a novel gene involved in age-related hearing loss.

Authors:  Meritxell Espino Guarch; Mariona Font-Llitjós; Isabel Varela-Nieto; Paolo Gasparini; Manuel Palacín; Virginia Nunes; Silvia Murillo-Cuesta; Ekaitz Errasti-Murugarren; Adelaida M Celaya; Giorgia Girotto; Dragana Vuckovic; Massimo Mezzavilla; Clara Vilches; Susanna Bodoy; Ignasi Sahún; Laura González; Esther Prat; Antonio Zorzano; Mara Dierssen
Journal:  Elife       Date:  2018-01-22       Impact factor: 8.140

Review 6.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

7.  The Periventricular Nucleus as a Brain Center Containing Dopaminergic Neurons and Neurons Expressing Individual Enzymes of Dopamine Synthesis.

Authors:  Michael V Ugrumov; Ekaterina N Pavlova; Anna A Kolacheva; Liliya K Dil'mukhametova; Vsevolod V Bogdanov; Victor Blokhin; Tatiana S Pronina
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.